No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
TRIN Trinity Capital
- 14.630
- +0.150+1.04%
Close May 3 16:00 ET
723.87MMarket Cap9.20P/E (TTM)
14.720High14.500Low386.30KVolume14.500Open14.480Pre Close5.65MTurnover0.83%Turnover Ratio7.74P/E (Static)49.48MShares15.26052wk High1.16P/B677.84MFloat Cap9.85552wk Low2.08Dividend TTM46.33MShs Float15.260Historical High14.22%Div YieldTTM1.52%Amplitude8.074Historical Low14.631Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Trinity Capital Inc. (NASDAQ:TRIN) Q1 2024 Earnings Call Transcript
Trinity Capital Is Maintained at Buy by B. Riley Securities
Trinity Capital Is Maintained at Buy by B. Riley Securities
Trinity Cap Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 8.4% B. Riley Securities $16.5 → $16 Maintains Buy 03/18/2024 11.79% UBS $16 → $16.5 Maintains
B. Riley Adjusts Trinity Capital's Price Target to $16 From $16.50, Keeps Buy Rating
Trinity Capital (TRIN) has an average rating of buy and price targets ranging from $14 to $17, according to analysts polled by Capital IQ. Price: 14.76, Change: +0.05, Percent Change: +0.34
Analysts' Opinions Are Mixed on These Financial Stocks: Trinity Capital (TRIN) and National Australia Bank Limited (OtherNAUBF)
Q1 2024 Trinity Capital Inc Earnings Call
Comments
Trinity Capital Inc. is thrilled to add Formlogic to its portfolio, expecting the company's expansion. Formlogic's CEO is keen to modernize the industrial supply chain and keep skilled manufacturing in the US.
Press Release: Trinity Capital Inc. Provides $20 Million Equipment Financing to FormlogicTrinity Capital believes that Carr's experience in the venture sphere will be invaluable as the company continues to grow and invest in disruptive companies. Carr is excited to join Trinity and contribute to its continued growth.
Trinity sees potential for advancements in gene therapy through Taysha's Rett syndrome treatments. Taysha believes the support from Trinity strengthens its vision to transform lives of patients with devastating diseases.
ColumnsToday's pre-market stock movers: RCUS, ANY, CGNT, XPOF and more
Gainers:
• $Arcus Biosciences(RCUS.US$ +11.2% (appointed to join S&P SmallCap 600)
• $Sphere 3d(ANY.US$ +10.13% (mutually agreed to terminate merger agreement with Gryphon Digital Mining)
• $Theravance Biopharma(TBPH.US$ +3.05% (announced results from Study 0170)
• $Carnival(CUK.US$ +4.7% (reported that March 28-April 3 was the busiest booking week in company history)
• $Castle Biosciences(CSTL.US$ +4.4% (agreed to acquire Althe...
• $Arcus Biosciences(RCUS.US$ +11.2% (appointed to join S&P SmallCap 600)
• $Sphere 3d(ANY.US$ +10.13% (mutually agreed to terminate merger agreement with Gryphon Digital Mining)
• $Theravance Biopharma(TBPH.US$ +3.05% (announced results from Study 0170)
• $Carnival(CUK.US$ +4.7% (reported that March 28-April 3 was the busiest booking week in company history)
• $Castle Biosciences(CSTL.US$ +4.4% (agreed to acquire Althe...
12
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg